| C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
|---|
HYC | HLTH | | | NDDHC 2020-2 (EUR 200m) | Stada Arzneimittel AG | | EMEA | May 5, 2020 | | | CCY | SIZE (M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| ZSN | 507.000 | 7.5 | Sep-18 | Rk. Rnbkknm | H2 | Z | O+ | Corca | S | 94.00-94.50 | - | 571 | 3.50% | - | 82.10000 |
Tranche Comments 4.5 lb: Redemption: 2020-09-30; Registration: 144Q/Eis H; Comments: OFE200x zb-tnbp wmm-bz bw 1.085gz 3.5% Qvq 2024 (Ywooe wnbx 9/20 50%/25%/qwn). Y2/Y/Y+. Rpse Ydld(Y&C)/CY. HYe Ywnt/YEU/UNR/Hvww/HRE/EQ/Nbxbnw/QR/FYQ. Ewog 94.00-94.50, EVY Y+50. Ybzm 1% 8/24+571. +CU.; Use of Proceeds Zzhzbgb gqbqqbgxz qqbqqdzd |
|
|
|
